| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,630,000,000 |
| Market
Cap: |
385.74(B) |
| Last
Volume: |
14,620,778 |
Avg
Vol: |
8,298,446 |
| 52
Week Range: |
$144.38 - $174.48 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
| |
MAJOR MARKET |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 21 |
| Guru Rank Value : 20.3 |
| Guru Occurances : 6 |
|
|
|
|
|
| |
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
8,891 |
68,288 |
115,451 |
513,708 |
| Total Sell Value |
$1,441,765 |
$10,723,734 |
$18,652,688 |
$87,322,011 |
| Total People Sold |
1 |
2 |
5 |
10 |
| Total Sell Transactions |
1 |
2 |
5 |
23 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kapusta Ronald A |
Controller, CAO |
• • – |
2016-07-22 |
4 |
S |
$125.01 |
$366,896 |
D/D |
(2,935) |
25,725 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-07-21 |
4 |
OE |
$58.33 |
$171,199 |
D/D |
2,935 |
28,660 |
|
- |
|
| Pruden Gary J |
Exec VP, WW Chair, Med Devices |
• • – |
2016-06-07 |
4 |
S |
$116.03 |
$1,129,552 |
D/D |
(9,735) |
43,630 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-06-07 |
4 |
S |
$115.79 |
$347,381 |
D/D |
(3,000) |
25,725 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-06-07 |
4 |
OE |
$58.33 |
$174,990 |
D/D |
3,000 |
28,725 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-05-10 |
4 |
S |
$114.77 |
$454,157 |
D/D |
(3,957) |
25,725 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-05-10 |
4 |
OE |
$58.33 |
$230,812 |
D/D |
3,957 |
29,682 |
|
- |
|
| Stoffels Paulus |
Chief Scientific Officer |
• • – |
2016-02-17 |
4 |
S |
$102.43 |
$12,803,250 |
D/D |
(125,000) |
122,543 |
|
- |
|
| Stoffels Paulus |
Chief Scientific Officer |
• • – |
2016-02-17 |
4 |
OE |
$72.54 |
$9,067,500 |
D/D |
125,000 |
247,543 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-02-08 |
4 |
D |
$100.87 |
$106,317 |
D/D |
(1,054) |
25,725 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
26,779 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,598 |
26,023 |
|
- |
|
| Peterson Sandra E |
Group Worldwide Chairman |
• • – |
2016-02-08 |
4 |
D |
$101.87 |
$460,452 |
D/D |
(4,520) |
35,644 |
|
- |
|
| Peterson Sandra E |
Group Worldwide Chairman |
• • – |
2016-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,221 |
40,164 |
|
- |
|
| Peterson Sandra E |
Group Worldwide Chairman |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,633 |
37,943 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2016-02-08 |
4 |
D |
$101.87 |
$4,111,575 |
D/D |
(40,361) |
176,849 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2016-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
19,769 |
217,210 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
67,933 |
197,441 |
|
- |
|
| Ullmann Michael H |
VP, General Counsel |
• • – |
2016-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
800 |
91,455 |
|
- |
|
| Ullmann Michael H |
VP, General Counsel |
• • – |
2016-02-08 |
4 |
D |
$101.87 |
$1,087,462 |
D/D |
(10,675) |
92,255 |
|
- |
|
| Ullmann Michael H |
VP, General Counsel |
• • – |
2016-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,859 |
102,930 |
|
- |
|
| Ullmann Michael H |
VP, General Counsel |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,697 |
98,071 |
|
- |
|
| Fasolo Peter |
VP, Global Human Resources |
• • – |
2016-02-08 |
4 |
D |
$101.87 |
$1,280,404 |
D/D |
(12,569) |
49,407 |
|
- |
|
| Fasolo Peter |
VP, Global Human Resources |
• • – |
2016-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,464 |
61,976 |
|
- |
|
| Fasolo Peter |
VP, Global Human Resources |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,777 |
56,512 |
|
- |
|
606 Records found
|
|
Page 21 of 25 |
|
|
1.39 (0.96%) 
